| Ident. | Authors (with country if any) | Title |
|---|
| 000160 (2011) |
Bozik [États-Unis] ; Mather [États-Unis] ; Kramer [États-Unis] ; Gribkoff [États-Unis] ; Ingersoll [États-Unis] | Safety, Tolerability, and Pharmacokinetics of KNS‐760704 (Dexpramipexole) in Healthy Adult Subjects |
| 000260 (2011) |
Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease |
| 000549 (2010) |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
| 000732 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 000996 (2009) |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
| 000A16 (2009) |
Lesley Wise [Royaume-Uni] ; John Parkinson [Royaume-Uni] ; June Raine [Royaume-Uni] ; Alasdair Breckenridge [Royaume-Uni] | New approaches to drug safety: a pharmacovigilance tool kit |
| 001249 (2006) |
Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis] | Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease |
| 001309 (2006) |
P. Odin [Allemagne] ; C. Oehlwein [Allemagne] ; A. Storch [Allemagne] ; U. Polzer [Allemagne] ; G. Werner [Allemagne] ; R. Renner [Allemagne] ; M. Shing [Allemagne] ; A. Ludolph [Allemagne] ; P. Schüler [Allemagne] | Efficacy and safety of high‐dose cabergoline in Parkinson's disease |
| 001310 (2006) |
Vincent Chung [Hong Kong] ; Liang Liu [Hong Kong] ; Zhaoxiang Bian [Hong Kong] ; Zhongzhen Zhao [Hong Kong] ; Wai Leuk Fong [Hong Kong] ; Wan Fung Kum [Hong Kong] ; Jing Gao [Hong Kong] ; Min Li [Hong Kong] | Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: A systematic review |
| 001469 (2005) |
J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Jürgen Köster [Allemagne] ; Gianni Pezzoli [Italie] ; Leandro Provinciali [Italie] | Long‐term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial |
| 001579 (2004) |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 001898 (2002) |
Werner Poewe [Autriche] ; G. Deuschl ; A. Gordin [Finlande] ; E. Kultalahti [Finlande] ; M. Leinonen [Finlande] | Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6‐month randomized placebo‐controlled double‐blind study in Germany and Austria (Celomen study) |
| 001A00 (2001) |
V. V. Myllyl ; E. Kultalahti [Finlande] ; H. Haapaniemi [Finlande] ; M. Leinonen [Finlande] | Twelve‐month safety of entacapone in patients with Parkinson’s disease |
| 001A03 (2001) |
W. J Weiner [États-Unis] ; S. A Factor [États-Unis] ; Joseph Jankovic [États-Unis] ; R. A Hauser [États-Unis] ; J. W Tetrud [États-Unis] ; C. H Waters [États-Unis] ; L. M Shulman [États-Unis] ; P. M Glassman [États-Unis] ; B. Beck [États-Unis] ; D. Paume [États-Unis] ; C. Doyle [États-Unis] | The long-term safety and efficacy of pramipexole in advanced Parkinson's disease |
| 001A75 (2001) |
S. Giménez-Roldán [Espagne] ; D. Mateo [Espagne] ; E. Navarro [Espagne] ; M. M Ginés [Espagne] | Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis |
| 001B64 (2000) |
Claudia Ramaker [Pays-Bas] ; Willem Johan T. Van De Beek [Pays-Bas] ; Martijn J. J. Finken [Pays-Bas] ; Bob J. J. Van Hilten [Pays-Bas] | The efficacy and safety of adjunct bromocriptine therapy for levodopa‐induced motor complications: A systematic review |
| 001B71 (2000) |
A.-C. Bachoud-Lévi [France] ; C. Bourdet [France] ; P. Brugières [France] ; J.-P. Nguyen [France] ; T. Grandmougin [France] ; B. Haddad [France] ; R. Jény [France] ; P. Bartolomeo [France] ; M.-F. Boissé [France] ; G. Dalla Barba [France] ; J.-D. Degos [France] ; A.-M. Ergis [France] ; J.-P. Lefaucheur [France] ; F. Lisovoski [France] ; E. Pailhous [France] ; P. Rémy [France] ; S. Palfi [France] ; G. L. Defer [France] ; P. Cesaro [France] ; P. Hantraye [France] ; M. Peschanski [France] | Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease |
| 001C36 (2000) |
Erica S. Zado [États-Unis] ; David J. Callans [États-Unis] ; Charles D. Gottlieb [États-Unis] ; Steven P. Kutalek [États-Unis] ; Sabrina L. Wilbur [États-Unis] ; Fania L. Samuels [États-Unis] ; Scott E. Hessen [États-Unis] ; Colin M. Movsowitz [États-Unis] ; John M. Fontaine [États-Unis] ; Stephen E. Kimmel [États-Unis] ; Francis E. Marchlinski [États-Unis] | Efficacy and safety of catheter ablation in octogenarians |
| 002033 (1997) |
V. V. Myllyl [Finlande] ; M. Jackson [Royaume-Uni] ; J. P. Larsen [Norvège] ; H. Baas [Allemagne] | Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial |
| 002772 (1990) |
Arjun D. Sharma [États-Unis] ; George J. Klein [États-Unis] ; Raymond Yee [États-Unis] | Intravenous adenosine triphosphate during wide QRS complex tachycardia: Safety, therapeutic efficacy, and diagnostic utility |
| 002A77 (1983) |
Charles D. Swerdlow [États-Unis] ; Jeanette O. Yu [États-Unis] ; Eric Jacobson [États-Unis] ; Susan Mann [États-Unis] ; Roger A. Winkle [États-Unis] ; Jerry C. Griffin [États-Unis] ; David L. Ross [États-Unis] ; Jay W. Mason [États-Unis] | Safety and efficacy of intravenous quinidine |
